approval · primary record
LAZERTINIB MESYLATE
FDA · NDA · 2026-04-30
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2026-04-30 |
| Brand | LAZCLUZE |
| Sponsor | JANSSEN BIOTECH |
| Route | ORAL |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T10:40:06.389Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:LAZERTINIB MESYLATE:2026-04-30
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Lazertinib Mesylate · compound